Quantitative detection of survivin in malignant pleural effusion for the diagnosis and prognosis of lung cancer
- 18 January 2009
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 273 (2), 331-335
- https://doi.org/10.1016/j.canlet.2008.08.023
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cell division and cell survival in the absence of survivinProceedings of the National Academy of Sciences, 2004
- Pathways of apoptotic and non-apoptotic death in tumour cellsNature Reviews Cancer, 2004
- Improving tumor cell detection in pleural effusions by interphase cytogeneticsCytometry Part B: Clinical Cytometry, 2003
- Survivin study: What is the next wave?Journal of Cellular Physiology, 2003
- Validating survivin as a cancer therapeutic targetNature Reviews Cancer, 2003
- Clinical Uses of Tumor Markers: A Critical ReviewCritical Reviews in Clinical Laboratory Sciences, 2001
- IAP family proteins---suppressors of apoptosisGenes & Development, 1999
- Telomerase activity in pleural effusions: diagnostic significance.Journal of Clinical Oncology, 1998
- Diagnosis and management of malignant pleural effusionsThe American Journal of Surgery, 1995
- Immunocytochemistry and ELISA Quantitation of Mucin for Diagnosis of Malignant Pleural EffusionsAmerican Review of Respiratory Disease, 1992